News/Health

A new analysis of blood samples from 24,000 Americans taken early last year is the latest and largest study to suggest the new coronavirus may have popped up in the U.S. in December 2019 — weeks before cases were first recognized by health officials.

American cardiologist and researcher Eric Topol says it’s the Canadian ‘culture.’ But other experts say it’s a confluence of factors that put Canada on track to become world leader in percentage of population with at least one dose of COVID-19 vaccine.

Canada is poised to battle back more contagious coronavirus variants that threaten to jeopardize reopening plans across the country due to a huge uptick in vaccine supply, a willingness from Canadians to get the shots and some promising new vaccine research. 

Canada is poised to battle back more contagious coronavirus variants that threaten to jeopardize reopening plans across the country due to a huge uptick in vaccine supply, a willingness from Canadians to get the shots and some promising new vaccine research. 

COVID-19 deaths led to a five-month decrease in life expectancy at birth last year, recent data released by Statistics Canada suggest, potentially putting the country at a level not seen in seven years.

Citing the need for speed against the growing threat of the coronavirus delta variant, infectious diseases specialists say the wait for a second dose should only be eight weeks, regardless of what kind of vaccine people got as their first dose.

Canada still hasn’t provided clear guidance to fully vaccinated Canadians on what they can and can’t do safely as the number of second doses of COVID-19 vaccines ramps up across the country and travel restrictions are set to ease.

The COVID-19 pandemic has left an estimated backlog of 15.9 million surgeries in Ontario, including MRIs, cataract surgeries, joint replacements and coronary bypass surgeries, according to the Ontario Medical Association. Doctors say they’re also worried about a decline in preventative screenings.

A Canadian research team has published new evidence highlighting a combination of two treatments that could help patients suffering from a rare, but potentially-deadly, post-vaccine blood clot condition.